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Although positive airway pressure(PAP) devices have become themainstay of treatment for obstruc-
tive sleep apnoea, not all patients can or
will use PAP on a nightly basis. Many
patients find taking a bulky PAP unit on
business or vacation trips a burden. In
this issue of Thorax Smith and Stradling
attempt to show that a simple non-
adjustable oral appliance may be used in
place of PAP on a short term basis.1
Unfortunately, in only nine of the 50
patients entered into the study was their
sleep apnoea controlled with the appli-
ance.
This low success rate of 18% does not
concur with the published literature
which has reported a success rate of 81%
in patients withmild and 60% in patients
with moderate sleep apnoea.2 Part of the
difference between this study and the
previous literature may be related to the
type of device used and side effects from
the device. Smith and Stradling em-
ployed a device that had previously been
shown to be effective in controlling
snoring.3 It consists of two customised
sports-type mouth guards fused together
to place the mandible in a forward posi-
tion set at approximately 75% of maxi-
mum mandibular protrusion. The device
covers both the teeth and the gums, so it
differs from more commonly used de-
vices such as the Herbst and the Klear-
way which cover only the teeth and are
adjustable, allowing gradual advance-
ment of the mandible to a forward posi-
tion at night to open the pharynx and
prevent snoring and sleep apnoea.
The difference in appliance configura-
tion probably contributed to the low suc-
cess rate. Thirty one of the subjects stud-
ied by Smith and Stradling gave up the
device due to intolerable side effects such
as sore gums, excessive salivation, and
painful masseter muscles or temporo-
mandibular joints. This contrasts mark-
edly with other experiences with the
appliance. We previously reported a
study of 19 patients who had failed with
nasal CPAP and changed to treatment
with the Herbst mandibular advance-
ment device.4 At the time of the follow
up sleep studies no patient reported pain
or discomfort while wearing the remov-
able Herbst appliance. Tegelberg and col-
leagues reported 45 patients randomised
to treatment with an oral appliance
adjusted to 50% of maximum mandibu-
lar protrusion.5 Only one patient with-
drew from treatment for side effects—
specifically, the patient developed
recurrent aphthous ulcers related to an
allergic reaction to the acrylic polymer.
Fritsch et al randomised patients to
treatment with either a Herbst appliance
or an appliance developed at their centre
(Monobloc) initially set at 75% maxi-
mum mandibular protrusion.6 Although
side effects were common with the two
appliances (mucosal dryness, tooth dis-
comfort, and excessive salivation), all the
symptoms were mild and none of the
subjects discontinued treatment because
of side effects. Mehta and colleagues
randomised 28 patients to treatment
either with a control oral plate that did
not advance the mandible or with a
mandibular advancement split that ad-
vanced the mandible to the most protru-
sive position that the patient could com-
fortably maintain.7 Twenty one of the 24
patients completed the protocol. Side
effects, which included excessive saliva-
tion, gum irritation, mouth dryness, jaw
discomfort, and tooth grinding were
mild to moderate and lasted a maximum
of 3 weeks. None of the patients stopped
using their device because of the side
effects. Furthermore, two randomised
crossover studies of PAP and oral appli-
ances have shown that mandibular ad-
vancement was better tolerated in mild
to moderate sleep apnoea and preferred
to nasal PAP.8 9
Even in those patients who were able
to tolerate their mandibular advance-
ment device, Smith and Stradling found
that their sleep apnoea was not well con-
trolled with the appliance. One reason
may have been that the patients did not
have their appliances suitably adjusted.
The authors arbitrarily chose a specific
mandibular protrusion and then studied
the patients at that setting. Setting a
mandibular position for an oral appli-
ance may not be that simple. Kato et al
reported a dose-dependent effect of
mandibular advancement on the severity
of sleep apnoea.10 Clinical protocols in
patients with adjustable Herbst or Klear-
way appliances involve a slow advance-
ment of the mandible until snoring and
daytime sleepiness have resolved. At this
point patients using an appliance are
sent for repeat polysomnographic evalu-
ation to see if further adjustments need
to be made to the appliance. In our clinic
patients on nasal CPAP who would like
to use an appliance for vacation or busi-
ness trips are not allowed to switch to an
appliance unless it is adequately control-
ling their sleep apnoea. One could argue
that giving an appliance with an arbi-
trarily fixed mandibular protrusion to a
patient with sleep apnoea is akin to arbi-
trarily switching a patient with an appli-
ance to an arbitrary PAP pressure of, for
example, 8 or 10 cm H2O.
The response of a patient to an oral
appliance may also be affected by
pharyngeal anatomy; this is not men-
tioned by Smith and Stradling. Patients
with large tonsils, for example, may not
respond to an oral appliance because of
the degree of baseline pharyngeal ob-
struction. In a series of patients who had
failed uvulopalatopharyngoplasty and
who then went on to oral appliance
therapy, we reported one patient in
whom an oral appliance did not control
his sleep apnoea.11 On initial testing he
had a baseline apnoeic/hypopnoeic
index (AHI) of 43 episodes/hour. Since
he could not tolerate nasal CPAP he was
fitted with a Herbst appliance. The
repeat AHI with the Herbst appliance in
place was 56 episodes/hour. Because he
was significantly symptomatic he un-
derwent a uvulopalatopharyngoplasty,
following which the AHI was 29
episodes/hour. He was then tried on the
appliance again and a repeat sleep study
indicated control of his sleep apnoea
with an AHI of 8 episodes/hour.
In summary, Smith and Stradling
have shown that, in their hands, their
appliance was not a good alternative to
PAP therapy. Their results were ham-
pered by significant side effects from the
appliance and poor control of the sleep
apnoea. Although it is possible that their
results could be extended to bite-block
type appliances, it is difficult to extrapo-
late the results to more sophisticated
adjustable mandibular devices.
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The ability of land animals to oxygen-ate via the lung as they developedfrom aquatic species means that a
system also evolved for protecting the
lung from flooding—the glottis. Al-
though in man this is considered prima-
rily as an organ of speech, disturbance of
its protective function will threaten the
integrity of the lung. While obstructive
conditions in the larynx can cause
breathlessness, abnormal function of an
otherwise structurally normal larynx
can also lead to symptoms. Such a
condition is vocal cord dysfunction,
characterised by paradoxical movement
of the vocal cords resulting in marked
reductions in airflow and
breathlessness.1
During normal respiration the false
vocal cords move very little while the
true cords abduct slightly during both
inspiration and expiration.2 In vocal cord
dysfunction, paradoxical movement of
the true and/or false cords occur during
inspiration, expiration, or both.2 3 Vocal
cord dysfunction frequently co-exists
with asthma4 5 and is usually considered
as being exclusively associated with
psychopathology,1 4 a view which is per-
petuated in part by the diagnosis only
being considered in that situation. How-
ever, vocal cord dysfunction can occur in
psychologically normal patients—for ex-
ample, after upper respiratory tract
infections6 or thyroid surgery.7 Diagnos-
tic confirmation is not always easy. The
flow-volume loop may reveal either
extrathoracic upper airway obstruction8
or ending of the inspiratory limb below
total lung capacity,9 10 while direct visu-
alisation of the cords may detect para-
doxical cord adduction but usually only
after exposing the subject to a known
trigger such as perfume.11 However, both
these methods have low sensitivity,
albeit high specificity.
LARYNGEAL
HYPERRESPONSIVENESS
Laryngeal hyperresponsiveness (analo-
gous to bronchial or nasal hyperrespon-
siveness in asthma or allergic rhinitis)
may underlie vocal cord dysfunction, as
shown by Bocca et al.12 They found laryn-
geal hyperresponsiveness in the majority
of patients who presented with recurrent
episodes of wheeze by showing deforma-
tion of the changes in the flow-volume
loop after histamine challenge, although
the reproducibility of this measure can
be questioned. However, inhalation of
histamine or methacholine has been
shown to cause laryngeal narrowing in
both normal and asthmatic subjects
(using photography,13 fluoroscopy,14 or
laryngeal sounds15 16) and in those with
acute severe asthma14 15 17 and with
chronic asthma on exercise.18 Conversely,
laryngeal widening occurs in normal
subjects following mechanical
stimulation19 and in both normal and
mild asthmatic subjects on exercise18 and
during panting.14 20 Panting overrides the
glottic narrowing induced by metha-
choline in stable asthma but not that
seen in acute severe asthma.14 Inflamma-
tory and irritant stimuli can thus cause a
transient or a longer lasting tendency to
laryngeal narrowing—that is, laryngeal
hyperresponsiveness—which will thus
contribute to wheezy breathlessness. In
addition, antigen handling cells can be
found in the laryngeal mucosa,21 which
suggests that allergens may be impor-
tant in the development of laryngeal
hyperresponsiveness. However, the pres-
ence of inflammation alone does not
explain why this irritable state is main-
tained over time.
ALTERED AUTONOMIC BALANCE
An altered state of autonomic balance,
maintained by the activity of more
central brain regions with the potential
strongly to influence autonomic func-
tion, could underlie this response. These
areas include sites in the medulla,
midbrain and the prefrontal cortex, par-
ticularly medial areas 25 and 32 of
Brodmann,22 and are polysynaptically
linked with the larynx. Both true and
false vocal cords derive motor innerva-
tion from the vagus, while sensory fibres
from M3 muscarinic receptors (among
others) in the laryngeal mucosa23 pass
via the vagus to the medulla. Activity
within these areas directly influences
autonomic functions such as the respira-
tory and cardiac cycles and gut motility.
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Area 25 also receives inputs resulting
from a variety of factors such as stress,
emotion, and changes in ambient tem-
perature, and is thus well positioned to
act as a modulator of autonomic output
in response to inputs both from sensory
mucosal nerves and to these less specific
inputs.24 25
But what evidence is there for an
altered autonomic preset in certain indi-
viduals? Asthmatic subjects exposed to
sulphur dioxide at rest show a reduction
in parasympathetic tone while normal
subjects show an increase in tone,26 per-
haps mediated through rapidly adapting
receptors27 in the larynx.28 While such an
increase in vagal tone in normal subjects
in response to an inhaled irritant can be
construed as bronchoprotective, this ap-
parently paradoxical asthmatic response
may be due to an initial induction of
neurogenic inflammation by the irritant
followed by vagal inhibition.26 Once
upper airway hyperresponsiveness (on
the background of the change in auto-
nomic preset) is established, the absence
of quick recovery from an initiating epi-
sode could result in this autonomic
preset becoming persistent. Subsequent
further irritant stimuli would prevent or
slow recovery leading to persistent
symptoms.
VOCAL CORD DYSFUNCTION
Clinically, vocal cord dysfunction often
overlaps with the hyperventilation syn-
drome, a condition also deemed to be
largely psychological in origin29 in which
tachypnoea could be explained by the
presence of laryngeal hyperresponsive-
ness and consequent glottic narrowing.
Vocal cord dysfunction can mimic or
co-exist with severe asthma1 5 and appor-
tioning the symptoms of the two can be
difficult. Preliminary findings in severe
asthma30 suggest that the increase in
parasympathetic tone on lying flat is
exaggerated in severe asthma compared
with mild asthma, which could contrib-
ute to nocturnal symptoms in asthma
and in vocal cord dysfunction.
Vocal cord dysfunction may thus be
caused by laryngeal hyperresponsive-
ness, initiated by an initial inflammatory
insult and resulting in altered autonomic
balance which may be short lived or
become persistent. If persistent, subse-
quent stimuli (such as psychological
stressors or cold air) will induce local
parasympathetic reflexes causing airway
narrowing either at the glottic level
and/or in patients with asthma in the
lower airways. As such, this represents
an exaggeration of the role of the larynx
in lung protection. The altered auto-
nomic preset is likely to be primarily
driven by the highest centres of the cen-
tral nervous system such as area 25 of
the prefrontal cortex. These complex
interrelationships now need to be ex-
plored, as this may have profound impli-
cations in the diagnosis and manage-
ment of patients with difficult
respiratory symptoms.
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